MedPath

ROACTEMRA 20 mg/ml, CONCENTRADO PARA SOLUCION PARA PERFUSION

ROACTEMRA 20 mg/ml, CONCENTRADO PARA SOLUCION PARA PERFUSION

Commercialized
Register Number

08492003

Prescription Type

Uso Hospitalario

Authorization Date

Jan 26, 2009

Dosage Form

SOLUCIÓN INYECTABLE

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number08492003
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

TOCILIZUMABActive
Quantity: 20 mg
Name: TOCILIZUMAB

ATC CLASSIFICATION (3)

L04A
L04AC
L04AC07

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.